⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
Levi & Korsinsky Urges Millrose Properties, Inc. (MRP) Shareholders to Act Before Lead Plaintiff Deadline December 8, 2026
accessnewswire.com
MRP
Duolingo, Inc. (DUOL) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of December 7, 2026 Deadline
accessnewswire.com
DUOL
Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
globenewswire.com
GMAB
NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
globenewswire.com
NBP
Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
businesswire.com
AGEN
Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
businesswire.com
GMAB
BeOne Medicines報告TEVIMBRA聯合ZIIHERA在一線HER2陽性胃食管癌中持續帶來生存獲益
businesswire.com
ONC
Best AI Tools for Small Business Marketing (2026): CapCut Featured for Creating Professional Video and Visual Content by Expert Consumers
prnewswire.com
BYND
Borr Drilling Limited - Prospector 5 Rig Incident
prnewswire.com
BORR
Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
globenewswire.com
REGN